Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

465

Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France

Emmanuel Faure, Olivier Brugière, Sylvie Colin de Verdiere

    Emerging Infectious Diseases
    |October 25, 2023
    PubMed

    Insights

    Olorofim successfully treated Microascus spp. bronchopulmonary infections in complex patients. This antifungal offers promise for challenging mold-related respiratory infections.

    Area of Science:

    • Mycology
    • Infectious Diseases
    • Pulmonology

    Background:

    • Microascus spp. pose a significant threat in immunocompromised individuals, particularly lung transplant recipients.
    • Bronchopulmonary infections caused by molds are increasingly challenging due to intrinsic antifungal resistance.

    Discussion:

    • This report details three successful cases of treating Microascus spp. bronchopulmonary infections.
    • The cases involved a multiple-traumatized patient and two lung transplant recipients in France.
    • Olorofim demonstrated efficacy in these complex clinical scenarios.

    Key Insights:

    • Olorofim is a promising therapeutic option for Microascus spp. infections.
    • Successful treatment highlights the potential of novel antifungals against resistant molds.
    • Early and effective intervention is crucial for managing invasive fungal infections in vulnerable populations.

    Outlook:

    • Further research into olorofim's efficacy against a broader spectrum of resistant molds is warranted.
    • Investigating optimal dosing and treatment duration for olorofim in various patient populations is essential.
    • Developing new diagnostic and therapeutic strategies is critical to combat rising antifungal resistance in respiratory infections.
    Keywords:
    FranceM. cirrosus pneumoniaMicroascusMicroascus melanosporusfungiolorofimrespiratory infections

    More Related Videos

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    509
    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

    Published on: March 17, 2014

    22.8K

    Related Concept Videos

    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    217
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    338
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    145
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    2.6K
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    183
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    339